Stay updated on Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page.

Latest updates to the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a new Locations section listing Connecticut and Indiana. Removed HHS Vulnerability Disclosure link and updated the page revision to v3.3.3.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed from the page.SummaryDifference0.0%

- Check44 days agoChange DetectedRemoved the government funding/operational-status notice from the page. The study details and contact information remain available.SummaryDifference0.3%

- Check59 days agoChange DetectedThe screenshots show only minor UI/formatting adjustments with no changes to core study data such as eligibility criteria, interventions, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check88 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference4%

- Check95 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page.